U.S. federal trademark · Serial No. 97341559 · Reg. No. 7237702
Genetic testing for medical purposes; Consulting services in the field of genetic testing for medical purposes; Medical and health services relating to DNA, RNA, genetics, genetic testing and genetic sequencing in the field of oncology; Providing medical information via the preparation of medical reports, namely, diagnostic reports based on genetic tumor profile; Providing medical information via medical reports, namely, clinical reports providing disease treatment recommendations and information about disease treatment and prognosis; Providing medical information to healthcare professionals on cancer diagnostics, treatment and prognosis; Providing medical information via a website featuring information on patient genetic data for diagnosis and treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical laboratory services for the analysis of samples taken from patients, namely, analysis of biological tumor sample and genetic sequencing; Pathology services relating to the treatment of persons, namely, analysis of biological tumor sample for medical purposes; Laboratory testing services, namely, genetic testing in the field of oncology for analyzing, classifying, interpreting and diagnosing genetic data for medical diagnostic and treatment purposes
Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Genetic testing apparatus for medical purposes; Diagnostic kits comprising of test tubes, collection containers and tools, for collecting biological samples for use in medical testing
Scientific laboratory services in the field of genomics, namely, genetic sequencing, analysis and diagnosis of biological tumor sample; Platform as a Services (PAAS) featuring computer software platforms for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms that provide a diagnostic report based on genetic tumor profile; Platform as a Services (PAAS) featuring computer software platforms for analyzing genetic data and providing healthcare professionals information about a patient's diagnosis, prognosis and treatment recommendations
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.